Not recruiting
Psoriatic arthropathy
Not recruitingStudy to Predict Tofacitinib Effectiveness in Psoriatic Arthritis Patients Using Tofacitinib, Methotrexate, and Folic Acid
Registered drugNo placebo
Study to Predict Tofacitinib Effectiveness in Psoriatic Arthritis Patients Using Tofacitinib, Methotrexate, and Folic Acid
Registered drugNo placebo
- Disease:Psoriatic arthropathy
- Substances:EtanerceptMethotrexate+3
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Etanercept
